Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2010
04/07/2010EP2170826A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
04/07/2010EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
04/07/2010EP2170326A2 Compositions for the treatment of hyperphenylalaninemia
04/07/2010EP2170307A2 Inhibition of age formation
04/07/2010EP2170259A1 Slimming composition
04/07/2010EP2170105A1 Extract from palm leaves and a method for producing the same
04/07/2010EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
04/07/2010EP1208005B1 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
04/07/2010EP1121155B1 Site-directed dual pegylation of proteins
04/07/2010CN1977866B Poria weight-losing agent
04/07/2010CN1934090B Substituted N-cyclohexyl imidazolinones having an MCH-modulatory effect
04/07/2010CN1769298B Fusion protein with antitumour action and its coding gene and uses
04/07/2010CN101691568A Method of producing edible immobilized active probiotics
04/07/2010CN101691410A Marine oligosaccharide chromic compound having function of preventing and treating insulin resistance
04/07/2010CN101691400A Method for solid phase synthesis of bitter gourd MC-JJ2622 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ222 peptide analogs
04/07/2010CN101691399A Method for solid phase synthesis of bitter gourd MC-JJ6221 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6221 peptide analogs
04/07/2010CN101691398A Method for solid phase synthesis of bitter gourd MC-JJ2162 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ2162 peptide analogs
04/07/2010CN101691395A Method for solid phase synthesis of bitter gourd MC-JJ62 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ62 peptide analogs
04/07/2010CN101691394A Method for solid phase synthesis of bitter gourd MC-JJ6 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6 peptide analogs
04/07/2010CN101690816A Medicinal composition of calcium-containing antagonist, A II receptor antagonist and statins
04/07/2010CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor
04/07/2010CN101690795A Tianshen vessel-freeing granules for treating cardiovascular and cerebrovascular diseases
04/07/2010CN101690789A Chinese medicinal preparation for treating diabetes
04/07/2010CN101690780A Compound drug for treating diabetes and preparation method thereof
04/07/2010CN101690777A Formula of polygonatum chewable tablets and preparation method thereof
04/07/2010CN101690770A Preparation capable of reducing blood pressure and blood lipid and improving human immunity, and preparation method thereof
04/07/2010CN101690766A Gentle bath foam traditional Chinese medicine composite, preparation method thereof and application thereof in preparing drugs and health care products to cure cold-type fatigue syndrome and obesity
04/07/2010CN101690759A Health product for improving nutritional anemia and preparation method thereof
04/07/2010CN101690751A Hyperlipemia patient health preserving and protecting tea and method of preparing same
04/07/2010CN101690741A Function of lowering blood fat of grosvener siraitia
04/07/2010CN101690722A Composition for slimming
04/07/2010CN101199756B Medicament for treating diabetics
04/07/2010CN101032473B Sandwich type medical releasing film and preparing method thereof
04/07/2010CN101024038B Medicine composition with fat-clearing, blood-pressure-reducing functions
04/06/2010US7692010 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
04/06/2010US7692009 Reference standard for characterization of rosuvastatin
04/06/2010US7692008 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
04/06/2010US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
04/06/2010US7691967 Smart pro-drugs of serine protease inhibitors
04/06/2010US7691906 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock
04/06/2010US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability
04/06/2010US7691871 Multivitamin syrup for children or young adults
04/06/2010US7691834 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
04/06/2010US7691425 Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof
04/06/2010US7691420 comprising a catechin as found in green tea, e.g., epigallocatechin gallate, and ligand which activates the peroxisome proliferatoractivated receptor gamma
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2513738C Casr antagonist
04/06/2010CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them
04/06/2010CA2464846C Dibenzylamine compounds and pharmaceutical use thereof
04/06/2010CA2459009C Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
04/06/2010CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives
04/06/2010CA2453383C Piperidine derivatives as nmda receptor antagonists
04/06/2010CA2449899C Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
04/06/2010CA2445346C N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same
04/06/2010CA2416220C Preparation of phosphatase inhibitors
04/06/2010CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
04/01/2010WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
04/01/2010WO2010037127A1 Chromenone analogs as sirtuin modulators
04/01/2010WO2010036876A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
04/01/2010WO2010036613A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
04/01/2010WO2010035806A1 Solid pharmaceutical composition
04/01/2010WO2010035769A1 Improved antibody molecule
04/01/2010WO2010035750A1 Method for producing lipid
04/01/2010WO2010035749A1 Method for concentrating lipid
04/01/2010WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
04/01/2010WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035219A2 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035013A1 Krill oil powder and krill oil tablets
04/01/2010WO2010034706A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010034657A1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
04/01/2010WO2010034649A1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases
04/01/2010WO2010034500A1 Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists
04/01/2010WO2010034315A1 A deproteinised calf blood preparation for use in prevention or treatment of diabetic peripheral polyneuropathy
04/01/2010WO2010015849A3 Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
04/01/2010WO2010010157A3 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
04/01/2010WO2010006125A3 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs
04/01/2010WO2009138762A3 Therapeutic use of peptides
04/01/2010WO2008139845A8 Novel amide derivative
04/01/2010US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products
04/01/2010US20100081699 Yeast platform construction and screening methods
04/01/2010US20100081695 2-N-{5-[ [4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
04/01/2010US20100081694 Composition comprising at least one ppar agonist and a lipid component
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3
04/01/2010US20100081659 Sigma receptor inhibitors
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
04/01/2010US20100081656 Compositions and methods for modulating c-kit and pdgfr receptors
04/01/2010US20100081652 Cinnamoyl Compound and Use Thereof
04/01/2010US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
04/01/2010US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
04/01/2010US20100081642 Cb-1 receptor modulator pharmaceutical formulations
04/01/2010US20100081640 Pharmaceutical composition
04/01/2010US20100081626 Weight loss compositions and uses thereof
04/01/2010US20100081623 Novel tellurium compounds and their use as immunomodulators
04/01/2010US20100081608 Use of Human Chorionic Gonadotropin (hCG) by Oral-Sublingual or Injectable Route as an Appetite-Suppressant Agent.
04/01/2010US20100080862 Compositions and foods for improving lipid metabolism
04/01/2010US20100080784 Methods for treating cachexia and lymphopenia
04/01/2010DE19943491B4 Verbesserte Komprimate Improved compressed
1 ... 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 ... 1298